4//SEC Filing
Schroeder Blake 4
Accession 0001096906-22-000339
CIK 0001514946other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 6:04 PM ET
Size
5.8 KB
Accession
0001096906-22-000339
Insider Transaction Report
Form 4
Schroeder Blake
Director
Transactions
- Other
Convertible Note (Convertible into Common Stock)
2022-02-10$25000.00/sh+25,000$625,000,000→ 307,692 totalExercise: $0.08From: 2022-02-10Exp: 2032-02-10→ Common Stock (307,692 underlying)
Footnotes (1)
- [F1]This Note bears interest at a rate of 3% per annum. At the election of the Reporting Person, all principal and accrued interest under the Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion.
Documents
Issuer
AXIM BIOTECHNOLOGIES, INC.
CIK 0001514946
Entity typeother
Related Parties
1- filerCIK 0001708685
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 6:04 PM ET
- Size
- 5.8 KB